Insmed
INSM
INSM
114 hedge funds and large institutions have $970M invested in Insmed in 2017 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 43 increasing their positions, 30 reducing their positions, and 9 closing their positions.
Holders
114
Holders Change
+14
Holders Change %
+14%
% of All Funds
2.85%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
24
Increased
43
Reduced
30
Closed
9
Calls
$6.39M
Puts
$21.8M
Net Calls
-$15.5M
Net Calls Change
+$2.02M
Top Buyers
Top Sellers
| 1 |
1
T. Rowe Price Associates
Baltimore,
Maryland
|
$177M |
| 2 |
2
JPMorgan Chase & Co
New York
|
$17.1M |
| 3 |
3
Invesco
Atlanta,
Georgia
|
$360K |
| 4 |
O
4
OrbiMed
New York
|
$75.4M |
| 5 |
5
Morgan Stanley
New York
|
$7.03M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
ACP
126
Acuta Capital Partners
Redwood City,
California
| – | – | – | – |
|
|
SM
127
Sabby Management
Miami Beach,
Florida
| – | – | – | – |
|
128
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | – | – |
|
129
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $0 | 8 | +8 | New |
|
130
SEI Investments
Oaks,
Pennsylvania
| $0 | 24 | +24 | New |
|